Related Experiment Video
Updated: Dec 23, 2025
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
miR-484 is associated with disease recurrence and promotes migration in prostate cancer
Daniel Lee1,2, Wei Tang2, Tiffany H Dorsey2
1Medical Oncology Service and the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, U.S.A.
Background:
microRNAs (miRs) regulate the expression of protein-coding genes and play key roles in various biological processes, including development and immunity. However, dysregulation of miR expression is also involved in disease biology, including cancer.
Methods:
We utilized The Cancer Genome Atlas (TCGA) and other publicly available databases for miRs and mRNA expression in prostate cancer, selected miR-484 and investigated its role in prostate cancer biology and disease progression using in vitro studies.
Results:
Our data mining efforts revealed that increased miR-484 in prostate tumors associates with early disease recurrence, while miR-484 expression in human prostate cancer cells enhances cancer cell mobility. Using RNAseq and bioinformatics, we identified candidate target genes of miR-484 and generated a list of potential tumor suppressors. One candidate in this list was PSMG1. We applied luciferase assays and immunoblotting to confirm that miR-484 directly targets PSMG1. Additional in vitro assays with cancer cell lines showed that PSMG1 knockdown rescued the reduction in mobility brought on by miR-484 inhibition, pointing toward the existence of a miR-484-PSMG1 axis in prostate cancer.
Conclusions:
We hypothesize that miR-484 is an oncogene in the prostate that increases cancer cell mobility, with PSMG1 being a mir-484 target in this process.
Insights
Increased microRNA-484 (miR-484) in prostate cancer promotes cell mobility and early recurrence. This oncogenic miR-484 targets PSMG1, driving prostate cancer progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRs) are key regulators of gene expression.
- Dysregulated miRs are implicated in various diseases, including cancer.
Purpose of the Study:
- Investigate the role of miR-484 in prostate cancer biology and progression.
- Identify miR-484 targets and elucidate its functional mechanism.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) and public databases for miR and mRNA expression analysis.
- Conducted in vitro studies using prostate cancer cell lines.
- Employed RNA sequencing, bioinformatics, luciferase assays, and immunoblotting.
Main Results:
- Elevated miR-484 in prostate tumors correlates with early disease recurrence.
- miR-484 enhances prostate cancer cell mobility.
- Identified PSMG1 as a direct target of miR-484, forming a miR-484-PSMG1 axis.
Conclusions:
- miR-484 acts as an oncogene in prostate cancer, promoting cell mobility.
- The miR-484-PSMG1 interaction is a key mechanism in prostate cancer progression.
